A recent analysis of the NRG-RTOG 0534 "SPPORT" clinical trial evaluated the Luminal B (LumB) molecular subtype using the ...

Many patients with early-stage breast cancer do not consistently maintain the long-term hormone therapy prescribed after ...

Many patients with early-stage breast cancer do not consistently maintain the long-term hormone therapy prescribed after ...

If you are an FtM or FtX individual considering hormone therapy, you are likely already aware of some of the benefits and ...

New research published in The BMJ highlights important differences in thrombotic risks associated with different forms of menopausal hormone therapy (MHT). In a nationwide Danish study, oral MHT was ...

Menopause can usher in a host of disruptive symptoms like hot flashes, night sweats and sleep problems. Hormone therapy promises relief. But many women wonder about taking it. That’s because the ...

Starting hormone replacement therapy during perimenopause or early postmenopause may decrease cardiovascular disease risk by 22%, a new study suggests.

In addition, higher doses of oral HRT may slightly increase a woman's risk of experiencing a heart attack or stroke.

Changes from immediately after starting treatment to the early stages“Easier to trigger and an overwhelming increase in ...

A large Danish study finds the pill form of menopause hormone therapy carries a real clot risk that the skin patch does not.

Add Yahoo as a preferred source to see more of our stories on Google. Perhaps one of the most misunderstood elements of gender-affirming care is hormone therapy. (Getty Images; Illustration by ...

Oral menopause hormone therapy was associated with increased venous thromboembolism risk regardless of dose or treatment ...